Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 044195/0405 | |
| Pages: | 3 |
| | Recorded: | 11/21/2017 | | |
| Attorney Dkt #: | 118179.00001 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
4
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12983856
|
Filing Dt:
|
01/03/2011
|
|
Publication #:
|
|
Pub Dt:
|
07/05/2012
| | | | |
|
Title:
|
ANTI-HLA-E ANTIBODIES, THERAPEUTIC IMMUNOMODULATORY ANTIBODIES TO HUMAN HLA-E HEAVY CHAIN, USEFUL AS IVIG MIMETICS AND METHODS OF THEIR USE
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
13348602
|
Filing Dt:
|
01/11/2012
|
|
Publication #:
|
|
Pub Dt:
|
07/11/2013
| | | | |
|
Title:
|
ANTI-HLA CLASS-Ib ANTIBODIES MIMIC IMMUNOREACTIVITY AND IMMUNOMODULATORY FUNCTIONS OF INTRAVENOUS IMMUNOGLOBULIN (IVIg) USEFUL AS THERAPEUTIC IVIg MIMETICS AND METHODS OF THEIR USE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/19/2020
|
Application #:
|
13507537
|
Filing Dt:
|
07/05/2012
|
|
Publication #:
|
|
Pub Dt:
|
01/09/2014
| | | | |
|
Title:
|
Diagnostic and therapeutic potential of HLA-E monospecific monoclonal IgG antibodies directed against tumor cell surface and soluble HLA-E
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/13/2020
|
Application #:
|
14371248
|
Filing Dt:
|
07/09/2014
|
|
Publication #:
|
|
Pub Dt:
|
11/27/2014
| | | | |
|
Title:
|
ANTI-HLA CLASS-IB ANTIBODIES MIMIC IMMUNOREACTIVITY AND IMMUNOMODULATORY FUNCTIONS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) USEFUL AS THERAPEUTIC IVIG MIMETICS AND METHODS OF THEIR USE
|
|
|
Assignee
|
|
|
|
|
| 1855 S. DUNSMUIR AVE. |
| LOS ANGELES, CALIFORNIA 90019-5228 |
|
|
Correspondence name and address
|
| |
SQUIRE PATTON BOGGS /R PATHAK /ZS
|
| |
1801 PAGE MILL ROAD
|
| |
SUITE 110
|
| |
PALO ALTO, CA 94304
|
Search Results as of:
06/27/2024 05:56 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
